Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

SDSCX

BNY Mellon Small/Mid Cap Growth Fund Class I

SDSCX Mutual Fund Price & Analysis

The BNY Mellon Small/Mid Cap Growth Fund Class I (SDSCX) is a mutual fund that focuses on investing in small and mid-sized companies with strong growth potential. This fund is managed by BNY Mellon Investment Management, a leading global investment firm. With a Class I designation, this fund is typically only available to institutional investors and has a higher minimum investment requirement. The fund aims to provide long-term capital appreciation by investing in a diversified portfolio of small and mid-cap stocks across various industries. Investors in this fund can expect a higher level of risk but also the potential for higher returns.

SDSCX Mutual Fund Chart & Stats

Previous Close$25.85

Sub-CategorySmall Cap

Total Liabilities1.73M

Last Dividend Ex-Date

Dec 01, 2021

Expense Ratio0.76%

Holding Count86

Brandbny mellon investment funds i

Dividend YieldN/A

CategoryEquity

Total Assets2.07B

Shares OutstandingN/A

52-Week Range$21.16 - $27.16

SDSCX Mutual Fund News

PremiumBlurbs

Dexcom: Hold Rating with a Cautious Outlook Amidst Financial and Market Challenges

1d ago

DXCM

PremiumBlurbs

Dexcom’s Resilience and Growth Prospects: A Buy Recommendation Amidst Short-Term Headwinds

1d ago

DXCM

PremiumBlurbs

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Tenaya Therapeutics (TNYA) and Cue Biopharma (CUE)

1d ago

CUE

DXCM

PremiumBlurbs

Dexcom (DXCM) Receives a Buy from Piper Sandler

1d ago

DXCM

SDSCX Mutual Fund Smart Score

Neutral

Analyst Consensus

Moderate Buy

Average Price Target:
$32.62 (― Downside)

Learn more about TipRanks Smart Score

For Mutual Funds, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the Mutual Fund's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual Mutual Fund ticker.